Global Preeclampsia Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Preeclampsia Market was valued at $3.6 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 10.2% CAGR, to an estimated market size of $5.9 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global preeclampsia market includes the diagnostics (instruments, reagents, and consumables) and therapeutics (antihypertensive agents, anticonvulsants, and corticosteroids) used for the screening, management, and treatment of hypertensive disorders during pregnancy, typically occurring after 20 weeks of gestation.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Preeclampsia Market in the period 2025-30:
- The rising prevalence of lifestyle-related risk factors such as obesity, diabetes, and advanced maternal age is significantly increasing the incidence of preeclampsia globally.
- A major shift toward biomarker-based testing, specifically utilizing sFlt-1 and PlGF ratios, is improving early detection and clinical decision-making.
- The integration of artificial intelligence and advanced data analytics is enhancing the accuracy of risk stratification and diagnostic prediction models.
- There is a growing demand for point-of-care (POC) diagnostics to provide rapid results in both clinical and resource-constrained settings.
- Increased government funding and public health initiatives are focusing on reducing maternal mortality through standardized prenatal screening protocols.
- The market is seeing a surge in R&D investment aimed at developing novel disease-modifying therapies to address the current lack of curative options beyond delivery.
- Expansion of healthcare infrastructure in emerging economies, particularly in the Asia-Pacific region, is driving higher adoption of advanced diagnostic tools.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Diagnostics
- Therapeutics